PTC Therapeutics PTCT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$2.81M-100% | —— | $15.9M+115% | -$64.85M+34.6% | $866.56M+1,046% | ||
| $15.41M+113% | $12.9M+90.7% | $11.11M+71.3% | $7.58M+8.1% | $7.22M-87.0% | ||
| $23.42M+29.7% | $18.52M+7.4% | $19.43M-1.7% | $18.54M-3.6% | $18.06M-1.7% | ||
| -$10K-600% | —— | —— | —— | $2K+300% | ||
| $305K+2.0% | $313K+2.0% | $305K+1.7% | $302K+2.4% | $299K+1.0% | ||
| -$2.64M-20.6% | $26.78M+342% | $18.53M+496% | $10.78M+457% | -$2.19M-1,726% | ||
| -$68.71M-471% | $108.08M+428% | -$43.21M— | —— | $18.5M+443% | ||
| -$1.18M-107% | $22.94M— | $1.68M+121% | —— | $16.43M+117% | ||
| -$2.31M-404% | —— | -$9.18M-398% | -$16.86M-90.0% | -$458K-108% | ||
| -$1.52M-121% | —— | -$8.14M— | —— | $7.2M+999% | ||
| $1.21M+56.8% | —— | $1.62M+99.8% | $764K+90.5% | $774K+9.0% | ||
| $1.76M-1.6% | $1.83M+23.8% | $2M+11.2% | $1.84M-31.2% | $1.79M-0.1% | ||
| —— | —— | —— | —— | -$800K-700% | ||
| $40.39M-15.5% | —— | $6.47M-16.1% | —— | $47.79M+21.0% | ||
| -$59.04M-107% | —— | —— | —— | $870.1M+1,130% | ||
| $1.2M-30.6% | $2.37M-37.0% | $3.45M+560% | $1.32M— | $1.72M-82.0% | ||
| $454.67M+41.1% | $312.26M+138% | $204.1M+10.4% | $524.83M+180% | $322.34M+209% | ||
| $376.36M+175% | $359.55M+38.9% | $177.2M+14.9% | $110.4M+47.2% | $136.75M+122% | ||
| $156K-80.7% | $34.92M+1,179% | $252.75M+2,365% | $2.68M— | $808K-98.5% | ||
| —— | —— | —— | —— | $70K— | ||
| -$93.74M+49.2% | $0-100% | -$289.62M-579% | -$422.01M-540% | -$184.36M-60.4% | ||
| $6.4M-59.3% | $59.39M+155% | $16.83M+2,837% | $1.13M-58.3% | $15.75M+676% | ||
| —— | —— | —— | —— | $6.34M+39.4% | ||
| $6.4M-32.0% | $302.5M+1,043% | $15.22M— | $3.96M-98.4% | $9.41M+1,643% | ||
| -$1.52M-128% | $9.8M+213% | —— | $13.59M+362% | $5.39M+366% | ||
| -$147.9M-121% | $312.03M+22.1% | -$346.77M-169% | —— | $700.55M+1,634% | ||
| $2.16M0.0% | —— | $3.55M+64.4% | —— | $2.16M-41.2% | ||
| $4.11M+77.9% | $5.05M+95.6% | $6.1M+107% | $4.56M+38.2% | $2.31M-37.4% | ||
| $305K+2.0% | $313K+2.0% | $305K+1.7% | $302K+2.4% | $299K+1.0% | ||
| —— | —— | —— | —— | -$800K-700% | ||
| —— | —— | $8.81M+69.3% | —— | -$3.12M-34,789% | ||
| —— | —— | —— | —— | —— | ||
| $887K+139% | —— | —— | -$2.69M-676% | -$2.25M-737% | ||
| -$927K-1,104% | —— | —— | —— | -$77K— | ||
| —— | —— | —— | —— | —— | ||
| —— | $2.69M+97.2% | $2.69M+97.2% | $2.69M+97.2% | $2.69M+97.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | -$4.68M-941% | ||
| $1.59M+160% | -$1.14M+75.0% | -$2.33M— | $216K— | $611K+105% | ||
| -$1.18M-107% | $22.94M— | $1.68M+121% | —— | $16.43M+117% | ||
| $65.7M+32.3% | $65.85M+25.8% | $49.98M-5.2% | $49.67M-5.0% | $49.66M-0.8% | ||
| $46.84M+42.0% | $79.41M+50.9% | $64.06M+15.4% | $52.13M+8.3% | $32.97M+30.7% | ||
| $1.76M-1.6% | $1.83M+23.8% | $2M+11.2% | $1.84M-31.2% | $1.79M-0.1% | ||
| $156K-80.7% | $34.92M+1,179% | $252.75M+2,365% | $2.68M— | $808K-98.5% | ||
| $376.36M+175% | $359.55M+38.9% | $177.2M+14.9% | $110.4M+47.2% | $136.75M+122% | ||
| —— | —— | —— | —— | $70K— | ||
| $1.55M— | —— | —— | —— | —— | ||
| $1.47M— | —— | —— | —— | —— | ||
| -$1.52M-128% | $9.8M+213% | —— | $13.59M+362% | $5.39M+366% | ||
| —— | $6.66M— | $6.66M— | $6.66M— | $6.66M— | ||
| $5.29M+142% | —— | —— | $100K-87.6% | $2.19M-4.8% | ||
| —— | $0-100% | $381K-80.3% | $11K— | $374K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $26.83M+560% | —— | $850K-50.7% | ||
| -$60.24M-107% | —— | —— | —— | $868.38M+1,320% | ||
| -$60.24M-107% | —— | —— | —— | $868.38M+1,320% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does PTC Therapeutics generate?
- PTC Therapeutics (PTCT) generated $704.1M in operating cash flow over the trailing twelve months.
- What is PTC Therapeutics's free cash flow?
- After $8.3M of capital expenditures, PTC Therapeutics's free cash flow was $696.9M over the trailing twelve months, up 637.5% year over year.
- Where does PTC Therapeutics's cash flow data come from?
- Every line is extracted from PTC Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
